ANGEPASSTE DOSIS EINES KONTRASTMITTELS

European patent · EP3728046 · Deleted

Register entry

Publication number
EP3728046
Application number
EP18822374
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 20, 2018
Published
Oct 28, 2020
Granted
Aug 14, 2024
Deleted
Jul 23, 2025
Reason
Annual fee unpaid
IPC classes
B65B 3/00 (2006.01)
A61M 5/00 (2006.01)
A61M 5/142 (2006.01)
A61M 5/168 (2006.01)
A61M 5/172 (2006.01)
B65B 1/30 (2006.01)
B65B 3/26 (2006.01)
B65B 31/00 (2006.01)
B65B 59/00 (2006.01)
B65B 59/02 (2006.01)
Priority
GB 201721463 20.12.2017
PCT application
PCT/EP2018/086359 20.12.2018
PCT publication
WO2019/122223 27.06.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2025

  2. Jun 25, 2025

    Change

    Published in Swissreg on 25.06.2025

  3. Aug 14, 2024

    Granted

    Published in Swissreg on 14.08.2024

Parties

Holder

GE Healthcare AS

Nydalen, Nycoveien 1 P.O. Box 4220, 0485 Oslo, NO

Inventor

WYNN, Duncan

St Giles, Buckinghamshire HP8 4SP, GB

LANGSETH-MANRIQUE, Karina

0485 Oslo, NO

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.